Literature DB >> 31588021

Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.

Lichun Ma1, Maria O Hernandez2, Yongmei Zhao3, Monika Mehta3, Bao Tran3, Michael Kelly3, Zachary Rae3, Jonathan M Hernandez4, Jeremy L Davis4, Sean P Martin5, David E Kleiner6, Stephen M Hewitt7, Kris Ylaya7, Bradford J Wood8, Tim F Greten9, Xin Wei Wang10.   

Abstract

Cellular diversity in tumors is a key factor for therapeutic failures and lethal outcomes of solid malignancies. Here, we determined the single-cell transcriptomic landscape of liver cancer biospecimens from 19 patients. We found varying degrees of heterogeneity in malignant cells within and between tumors and diverse landscapes of tumor microenvironment (TME). Strikingly, tumors with higher transcriptomic diversity were associated with patient's worse overall survival. We found a link between hypoxia-dependent vascular endothelial growth factor expression in tumor diversity and TME polarization. Moreover, T cells from higher heterogeneous tumors showed lower cytolytic activities. Consistent results were found using bulk genomic and transcriptomic profiles of 765 liver tumors. Our results offer insight into the diverse ecosystem of liver cancer and its impact on patient prognosis. Published by Elsevier Inc.

Entities:  

Keywords:  VEGF; biodiversity; cholangiocarcinoma; hepatocellular carcinoma; liver cancer; microenvironmental reprogramming; single-cell; tumor ecosystem; tumor heterogeneity; tumor microenvironments

Mesh:

Substances:

Year:  2019        PMID: 31588021      PMCID: PMC6801104          DOI: 10.1016/j.ccell.2019.08.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

Review 1.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

Review 2.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

Review 3.  Unravelling biology and shifting paradigms in cancer with single-cell sequencing.

Authors:  Timour Baslan; James Hicks
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

4.  Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma.

Authors:  Hien Dang; Atsushi Takai; Marshonna Forgues; Yotsowat Pomyen; Haiwei Mou; Wen Xue; Debashish Ray; Kevin C H Ha; Quaid D Morris; Timothy R Hughes; Xin Wei Wang
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

5.  Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.

Authors:  Shaoping Ling; Zheng Hu; Zuyu Yang; Fang Yang; Yawei Li; Pei Lin; Ke Chen; Lili Dong; Lihua Cao; Yong Tao; Lingtong Hao; Qingjian Chen; Qiang Gong; Dafei Wu; Wenjie Li; Wenming Zhao; Xiuyun Tian; Chunyi Hao; Eric A Hungate; Daniel V T Catenacci; Richard R Hudson; Wen-Hsiung Li; Xuemei Lu; Chung-I Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-11       Impact factor: 11.205

6.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.

Authors:  Elham Azizi; Ambrose J Carr; George Plitas; Andrew E Cornish; Catherine Konopacki; Sandhya Prabhakaran; Juozas Nainys; Kenmin Wu; Vaidotas Kiseliovas; Manu Setty; Kristy Choi; Rachel M Fromme; Phuong Dao; Peter T McKenney; Ruby C Wasti; Krishna Kadaveru; Linas Mazutis; Alexander Y Rudensky; Dana Pe'er
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

7.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

8.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

9.  Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.

Authors:  F M Buffa; A L Harris; C M West; C J Miller
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

10.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

View more
  143 in total

1.  Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.

Authors:  Emilien Loeuillard; Jingchun Yang; EeeLN Buckarma; Juan Wang; Yuanhang Liu; Caitlin Conboy; Kevin D Pavelko; Ying Li; Daniel O'Brien; Chen Wang; Rondell P Graham; Rory L Smoot; Haidong Dong; Sumera Ilyas
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 2.  Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment.

Authors:  Amblessed E Onuma; Hongji Zhang; Hai Huang; Terence M Williams; Anne Noonan; Allan Tsung
Journal:  Gene Expr       Date:  2020-04-27

3.  Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.

Authors:  Shaolong Cao; Jennifer R Wang; Shuangxi Ji; Peng Yang; Yaoyi Dai; Shuai Guo; Matthew D Montierth; John Paul Shen; Xiao Zhao; Jingxiao Chen; Jaewon James Lee; Paola A Guerrero; Nicholas Spetsieris; Nikolai Engedal; Sinja Taavitsainen; Kaixian Yu; Julie Livingstone; Vinayak Bhandari; Shawna M Hubert; Najat C Daw; P Andrew Futreal; Eleni Efstathiou; Bora Lim; Andrea Viale; Jianjun Zhang; Matti Nykter; Bogdan A Czerniak; Powel H Brown; Charles Swanton; Pavlos Msaouel; Anirban Maitra; Scott Kopetz; Peter Campbell; Terence P Speed; Paul C Boutros; Hongtu Zhu; Alfonso Urbanucci; Jonas Demeulemeester; Peter Van Loo; Wenyi Wang
Journal:  Nat Biotechnol       Date:  2022-06-13       Impact factor: 54.908

Review 4.  Hypoxia-inducible factors and innate immunity in liver cancer.

Authors:  Vincent Wai-Hin Yuen; Carmen Chak-Lui Wong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 5.  Exploring liver cancer biology through functional genetic screens.

Authors:  Cun Wang; Ying Cao; Chen Yang; René Bernards; Wenxin Qin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-23       Impact factor: 46.802

Review 6.  Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.

Authors:  Renumathy Dhanasekaran
Journal:  Semin Liver Dis       Date:  2021-01-14       Impact factor: 6.115

Review 7.  Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.

Authors:  Juan Wang; Sumera Ilyas
Journal:  Expert Opin Investig Drugs       Date:  2020-12-28       Impact factor: 6.206

Review 8.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

9.  Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Lichun Ma; Limin Wang; Subreen A Khatib; Ching-Wen Chang; Sophia Heinrich; Dana A Dominguez; Marshonna Forgues; Julián Candia; Maria O Hernandez; Michael Kelly; Yongmei Zhao; Bao Tran; Jonathan M Hernandez; Jeremy L Davis; David E Kleiner; Bradford J Wood; Tim F Greten; Xin Wei Wang
Journal:  J Hepatol       Date:  2021-06-30       Impact factor: 25.083

Review 10.  Liver Cancer Immunity.

Authors:  Sumera Rizvi; Juan Wang; Anthony B El-Khoueiry
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.